Evaluation of USP apparatus 3 for dissolution testing of immediate-release products
Tóm tắt
Từ khóa
Tài liệu tham khảo
Borst I, Ugwu S, Beckett AH. New and extended application for USP drug release apparatus 3. Dissolut Technol. February 1997: 1–6.
U.S. Pharmacopeial Convention. United States Pharmacopeia XXII/National Formulary XVII. Suppl 4. Rockville, MD: USP. pp. 2510–2514.
Borst SI. Comparative pH-gradient dissolution of several oral dosage forms of iron. Drug Dev Ind Pharm. 1991; 17: 2333–2339.
Civiale C, Ritschel WA, Shiu GK, Aiache JM, Beyssac E. In vivo-in vitro correlation of salbutamol release from a controlled release osmotic pump delivery system. Meth Find Exp Clin Pharmacol. 1991; 13: 491–498.
Esbelin B, Beyssac E, AiAche JM, Shiu GK, Skelly JP. A new method of dissolution in vitro, the “Bio-Dis” apparatus: comparison with the rotating bottle method and in vitro in vivo correlations. J Pharm Sci. 1991; 80: 991–994.
Sanghvi PP, Nambiar JS, Shukla AJ, Collins CC. Comparison of three dissolution devices for evaluating drug release. Drug Dev Ind Pharm. 1994; 20: 961–980.
Rohrs BR, Burch-Clark DL, Witt MJ, Stelzer DJ. USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations. J Pharm Sci. 1995; 84: 922–926.
Sorascuchart W, Wardrop J, Ayres JW. Drug release from spray layered and coated drug-containing beads: effects of pH and comparison of different methods. Drug Dev Ind Pharm. 1999; 10: 1093–1098.
Food and Drug Administration. Guidance for Industry, Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. FDA, Rockville, MD: August 2000.
Food and Drug Administration. Guidance for Industry, Dissolution Testing of Immediate Release Solid Oral Dosage Forms. FDA, Rockville, MD: August 1997.